Skip to main content
Clinical Trials/NCT06667895
NCT06667895
Not Yet Recruiting
N/A

Influences of the Autonomic Nervous System on Experimental Pain Sensitization

Schweinhardt Petra1 site in 1 country146 target enrollmentNovember 4, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autonomic Nervous System Modulation
Sponsor
Schweinhardt Petra
Enrollment
146
Locations
1
Primary Endpoint
Magnitude of the Nociceptive Withdrawl Reflex
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

In this study, we want to investigate how pain processing and sensation are related to a certain part of the nervous system, the so-called autonomic nervous system.

For this purpose, we apply heat and pressure stimuli to the skin and test pain processing by means of ratings scales and sensory tests. Breathing, heart rate and sweat response are also measured. To assess the spinal cord level, we measure muscle response (measured by electromyography, EMG) to electrical stimulation. Additionally, sensory nerves will be stimulated at the ear and participants will also be given various questionnaires to complete.

Detailed Description

This study investigates the effects of autonomic regulation on pain perception and experimentally induced pain sensitivity. Participants come for one or two study visits, that will last approximately 3 hours. The study is divided into two phases: the pilot phase and the main experimental phase. During the pilot phase, the perception of pressure and heat stimuli, as well as spinal excitability, will be assessed before and during different types of electrical stimulation of sensory nerves at the outer ear. During the main experimental phase, skin sensitivity and spinal excitability will be assessed before and after repetitive heat stimulation and stimulation of sensory nerves at the outer ear. In both study phases, the activity of the autonomic nervous system will be assessed throughout the experiment, and questionnaires will be completed.

Registry
clinicaltrials.gov
Start Date
November 4, 2024
End Date
August 2026
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Schweinhardt Petra
Responsible Party
Sponsor Investigator
Principal Investigator

Schweinhardt Petra

Prof. Dr. med.

Balgrist University Hospital

Eligibility Criteria

Inclusion Criteria

  • Over 18 and below 40 years of age
  • Good general health
  • Able to give informed consent

Exclusion Criteria

  • Any major medical or psychiatric condition (e.g. heart disease, diabetes, autoimmune disorders, infectious diseases, major depressive disorder), any chronic pain condition, any respiratory problems, any acute pain at time of study
  • Inability to follow study instructions, e.g. due to language problems
  • Pregnancy (female participants will be asked if pregnancy could be possible)
  • Increased alcohol (\>2 (for women)/4 (for men) standard glasses per day or \>5 (for women)/4 (for men) glasses at least once a month within a few hours) or caffeine consumption (≥ 400mg per day)
  • Consumption of alcohol, drugs, analgesics within the last 24 h
  • Consumption of more than 100 mg of caffeine within the last 8 h
  • Scar tissue or generally reduced sensitivity in the designated testing site areas
  • Shoe size \< 38 (if experiment is conducted at the feet)
  • History of cardiovascular disease or carotid artery disease
  • Medication or Substances inferring with the autonomic nervous system or with pain sensitivity (e.g. Benzodiazepines, Nicotine)

Outcomes

Primary Outcomes

Magnitude of the Nociceptive Withdrawl Reflex

Time Frame: Before, during, and/or immediately after the intervention

Muscle responses of the biceps fermoris to an electrical stimulation of the sural nerve will be measured using an electromyogramm

Study Sites (1)

Loading locations...

Similar Trials